Teva Pharmaceutical Industries Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TEVA research report →
About the company
Teva Pharmaceutical Industries Limited functions as a global pharmaceutical enterprise, involved in the conception, manufacturing, marketing, and provision of a broad spectrum of generic, specialty, and biopharmaceutical products throughout North America, Europe, and various international markets. The company's diverse product range includes sterile items, hormones, potent drugs, and cytotoxic agents, available in numerous forms like tablets, capsules, injectable solutions, inhalable preparations, liquids, transdermal patches, topical ointments, and creams. Additionally, Teva develops, produces, and sells active pharmaceutical ingredients (APIs).
- CEO
- Richard D. Francis
- IPO
- 1982
- Employees
- 37,000
- HQ
- Tel Aviv, IL
Price Chart
- Market Cap
- $40.34B
- P/E
- 25.36
- P/S
- 2.34
- P/B
- 4.87
- EV/EBITDA
- 16.23
- Div Yield
- 0.00%
- Gross Margin
- 52.06%
- Op Margin
- 18.83%
- Net Margin
- 9.03%
- ROE
- 20.79%
- ROIC
- 11.17%
- Revenue
- $17.26B · 4.31%
- Net Income
- $1.41B · 186.03%
- EPS
- $1.23 · 184.83%
- Op Income
- $2.16B
- FCF YoY
- 53.27%
- 52W High
- $37.35
- 52W Low
- $14.99
- 50D MA
- $34.00
- 200D MA
- $29.40
- Beta
- 0.85
- Avg Volume
- 6.19M
Get TickerSpark's AI analysis on TEVA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 18, 26 | Shields Matthew | sell | 9,989 |
| Jun 11, 26 | Kalif Eliyahu Sharon | sell | 106,563 |
| Jun 5, 26 | BARER SOL J | other | 21,739 |
| Jun 5, 26 | BARER SOL J | other | 21,739 |
| Jun 5, 26 | Lichtenstein Chen | other | 14,492 |
| Jun 5, 26 | Lichtenstein Chen | other | 14,492 |
| Jun 5, 26 | Crane Rosemary A | other | 14,492 |
| Jun 5, 26 | Crane Rosemary A | other | 14,492 |
| Jun 5, 26 | Elstein Amir | other | 14,492 |
| Jun 5, 26 | Elstein Amir | other | 14,492 |
Our TEVA coverage
Recent articles, reports, and earnings notes.
No research on TEVA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate TEVA report →Similar companies
Peers in the same neighborhood.